WO2017084631A8 - 预防或治疗脂肪胰、改善脂肪胰引起的胰病变、糖尿病或其他相关病症之组合物及方法 - Google Patents

预防或治疗脂肪胰、改善脂肪胰引起的胰病变、糖尿病或其他相关病症之组合物及方法 Download PDF

Info

Publication number
WO2017084631A8
WO2017084631A8 PCT/CN2016/106607 CN2016106607W WO2017084631A8 WO 2017084631 A8 WO2017084631 A8 WO 2017084631A8 CN 2016106607 W CN2016106607 W CN 2016106607W WO 2017084631 A8 WO2017084631 A8 WO 2017084631A8
Authority
WO
WIPO (PCT)
Prior art keywords
fatty infiltration
relieving
diabetes
preventing
pancreas
Prior art date
Application number
PCT/CN2016/106607
Other languages
English (en)
French (fr)
Other versions
WO2017084631A1 (zh
WO2017084631A9 (zh
Inventor
胡幼圃
何欣恬
吴永恩
唐熙卉
Original Assignee
财团法人国际教育基金会
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 财团法人国际教育基金会 filed Critical 财团法人国际教育基金会
Priority to PL16865806.0T priority Critical patent/PL3378481T3/pl
Priority to ES16865806T priority patent/ES2949047T3/es
Priority to FIEP16865806.0T priority patent/FI3378481T3/fi
Priority to JP2018526113A priority patent/JP6914256B2/ja
Priority to US15/777,385 priority patent/US20180325840A1/en
Priority to CN201680067605.XA priority patent/CN109715170A/zh
Priority to EP16865806.0A priority patent/EP3378481B1/en
Priority to DK16865806.0T priority patent/DK3378481T3/da
Publication of WO2017084631A1 publication Critical patent/WO2017084631A1/zh
Publication of WO2017084631A8 publication Critical patent/WO2017084631A8/zh
Publication of WO2017084631A9 publication Critical patent/WO2017084631A9/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/428—Thiazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Medicinal Preparation (AREA)

Abstract

一种预防或治疗脂肪胰、改善脂肪胰引起的胰病变、糖尿病或其他相关病症之组合物及方法。
PCT/CN2016/106607 2015-11-19 2016-11-21 预防或治疗脂肪胰、改善脂肪胰引起的胰病变、糖尿病或其他相关病症之组合物及方法 WO2017084631A1 (zh)

Priority Applications (8)

Application Number Priority Date Filing Date Title
PL16865806.0T PL3378481T3 (pl) 2015-11-19 2016-11-21 Związek lub kompozycja do zapobiegania lub leczenia nacieku tłuszczowego trzustki
ES16865806T ES2949047T3 (es) 2015-11-19 2016-11-21 Compuesto o composición para prevenir o tratar la infiltración grasa del páncreas
FIEP16865806.0T FI3378481T3 (fi) 2015-11-19 2016-11-21 Yhdiste tai koostumus haiman rasva-infiltraation estoon tai hoitoon
JP2018526113A JP6914256B2 (ja) 2015-11-19 2016-11-21 膵臓脂肪浸潤を予防または治療し、膵臓脂肪浸潤に起因する膵臓病変、糖尿病または他の関連症状を緩和するための組成物、および方法
US15/777,385 US20180325840A1 (en) 2015-11-19 2016-11-21 Compositions and methods for preventing or treating fatty pancreas or ameliorating pancreas diseases caused by fatty pancreas, diabetes mellitus or other related disorders
CN201680067605.XA CN109715170A (zh) 2015-11-19 2016-11-21 预防或治疗脂肪胰、改善脂肪胰引起的胰病变、糖尿病或其他相关病症之组合物及方法
EP16865806.0A EP3378481B1 (en) 2015-11-19 2016-11-21 Compound or composition for preventing or treating pancreas fatty infiltration
DK16865806.0T DK3378481T3 (da) 2015-11-19 2016-11-21 Forbindelse eller sammensætning til forebyggelse eller behandling af pancreasfedtinfiltration

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562257707P 2015-11-19 2015-11-19
US62/257,707 2015-11-19

Publications (3)

Publication Number Publication Date
WO2017084631A1 WO2017084631A1 (zh) 2017-05-26
WO2017084631A8 true WO2017084631A8 (zh) 2018-09-13
WO2017084631A9 WO2017084631A9 (zh) 2019-01-17

Family

ID=58717399

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2016/106607 WO2017084631A1 (zh) 2015-11-19 2016-11-21 预防或治疗脂肪胰、改善脂肪胰引起的胰病变、糖尿病或其他相关病症之组合物及方法

Country Status (12)

Country Link
US (1) US20180325840A1 (zh)
EP (1) EP3378481B1 (zh)
JP (1) JP6914256B2 (zh)
CN (1) CN109715170A (zh)
DK (1) DK3378481T3 (zh)
ES (1) ES2949047T3 (zh)
FI (1) FI3378481T3 (zh)
HU (1) HUE062181T2 (zh)
PL (1) PL3378481T3 (zh)
PT (1) PT3378481T (zh)
TW (1) TWI797068B (zh)
WO (1) WO2017084631A1 (zh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110269855A (zh) * 2019-07-19 2019-09-24 辽宁大学 黄酮类小分子化合物在制备抑制胰脂肪酶活性药物中的应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5380737A (en) * 1989-05-04 1995-01-10 Sterling Winthrop Inc. Saccharin derivative proteolytic enzyme inhibitors
CN1840518A (zh) * 2005-08-18 2006-10-04 山东寻山水产集团有限公司 一种从海带中提取甘露醇的方法
JP2008007452A (ja) * 2006-06-28 2008-01-17 Ajinomoto Co Inc 膵β細胞保護剤
CN1911114B (zh) * 2006-08-25 2012-08-15 李罡 一种含三氯蔗糖的饮料
EP1925311A1 (en) * 2006-11-15 2008-05-28 Melbrosin International Produktions und Vertriebs GmbH & Co KG Use of a plant extract or plant juice
JP5327732B2 (ja) * 2007-08-31 2013-10-30 広島県 α−グルコシダーゼ阻害剤及びその製造方法
JPWO2010044371A1 (ja) * 2008-10-16 2012-03-15 国立大学法人群馬大学 インスリン分泌促進剤
ES2597955T3 (es) * 2009-02-11 2017-01-24 Ramot At Tel-Aviv University Ltd. Composiciones antisépticas que comprenden iones de plata y mentol y usos de las mismas
IT1396074B1 (it) * 2009-10-12 2012-11-09 Axioma S R L Composizione ad attivita' termogenetica potenziata e suo impiego nella prevenzione e trattamento dell'obesita'
EP2559346B1 (en) * 2011-08-15 2014-03-26 Symrise AG Oleanene-type triterpene glycosides as masking agents
CN102920683B (zh) * 2012-06-11 2013-08-14 江苏豪森药业股份有限公司 奥氮平口腔速溶膜
CN104490611B (zh) * 2014-12-12 2017-08-08 安徽新华学院 一种天然养发泡腾颗粒或泡腾片及其制备方法

Also Published As

Publication number Publication date
CN109715170A (zh) 2019-05-03
FI3378481T3 (fi) 2023-07-06
PL3378481T3 (pl) 2023-12-27
PT3378481T (pt) 2023-06-28
EP3378481A4 (en) 2019-07-10
JP2019511996A (ja) 2019-05-09
WO2017084631A1 (zh) 2017-05-26
WO2017084631A9 (zh) 2019-01-17
EP3378481A1 (en) 2018-09-26
HUE062181T2 (hu) 2023-09-28
TWI797068B (zh) 2023-04-01
DK3378481T3 (da) 2023-07-03
EP3378481B1 (en) 2023-04-05
JP6914256B2 (ja) 2021-08-04
ES2949047T3 (es) 2023-09-25
TW201720461A (zh) 2017-06-16
US20180325840A1 (en) 2018-11-15

Similar Documents

Publication Publication Date Title
EP3501527A4 (en) COMPOSITION FOR PREVENTING OR TREATING MENTAL DISORDER, CONTAINING A VESICLE DERIVED FROM BACTERIA OF A SPECIES ACTOBACILLUS
EP3677699A4 (en) STEEL MATERIAL FOR CEMENTED ELEMENT
MX2019000088A (es) Composiciones y metodos para detectar y tratar la diabetes.
EP3176276A4 (en) Steel for carbonitrided bearing
EP3283551A4 (en) ACTIVE LIGNIN COMPOSITION, PROCESS FOR PRODUCING THE COMPOSITION AND USE THEREOF
EP3395360A4 (en) METHOD FOR PREVENTING OR TREATING DIABETIC RETINOPATHY
WO2018101663A3 (ko) 생체 조직 투명화용 조성물 및 이를 이용한 생체 조직 투명화 방법
EP3550048A4 (en) STEEL FOR SOFT NITRATION AND COMPONENT
EP3556383A4 (en) INNOVATIVE METHOD FOR TREATING DIABETES
WO2018127612A3 (en) Compositions comprising lespedeza plant extract
MY194227A (en) Modulators of pcsk9 expression
AU2016362202A8 (en) Method for preventing or treating nosocomial pneumonia
EP3382051A4 (en) STEEL, CONSISTING OF CEMENTED STEEL, AND PROCESS FOR PRODUCING CEMENTED STEEL COMPONENT
MX2017015384A (es) Extension de horma de zapato.
EP3609522A4 (en) METHODS AND COMPOUNDS FOR THE TREATMENT OF DIABETES
EP3276023A4 (en) Steel for soft nitriding, components, and method for manufacturing same
CA3035115C (en) Nitrogenous heterocyclic aromatic compound, preparation method therefor, pharmaceutical composition thereof, and application thereof
EP3538124A4 (en) COMPOSITIONS AND METHODS FOR TREATING DIABETES, HIGH BLOOD PRESSURE AND HYPERCHOLESTERINEMIA
EP3576748A4 (en) SYSTEMS, COMPOSITIONS, AND PROCEDURES FOR TREATING DIABETES
EP3193610A4 (en) Selective nav1.7 inhibitors for the treatment of diabetes
WO2017084631A8 (zh) 预防或治疗脂肪胰、改善脂肪胰引起的胰病变、糖尿病或其他相关病症之组合物及方法
EP3778836A4 (en) GREASE COMPOSITION, MECHANISM COMPONENT AND PROCESS FOR THE PRODUCTION OF GREASE COMPOSITION
WO2015175884A3 (en) Compositions and methods for treating and preventing pancreatitis, renal injury and cancer
MX2019009200A (es) Composiciones y métodos para inhibir el reticulón 4.
EP3480197A4 (en) PYRROLOCHINONE-CHINON-MONONATRIUM, METHOD FOR THE PRODUCTION THEREOF AND COMPOSITION THEREWITH

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 16865806

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 15777385

Country of ref document: US

Ref document number: 2018526113

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2016865806

Country of ref document: EP